Beibei Qin

1PUBLICATIONS
2CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (1)

|Aug 04, 2022
An anti-CTLA-4 heavy chain-only antibody with enhanced T<sub>reg</sub> depletion shows excellent preclinical efficacy and safety profile.

Xin Gan, Qianqian Shan, He Li

Pageof 1